Delivra Successfully Demonstrates Targeted Pain Relief with Topical Ibuprofen
Published:28 Apr.2018    Source:Cision
Delivra Corp. ("Delivra", or "the Company") announced the ability to treat pain directly with a topical version of Advil™ (ibuprofen). Testing for effects on joint pain and inflammation, topical Delivra-ibuprofen formulation offers long-term pain and swelling reduction compared to oral ibuprofen.

The Delivra-ibuprofen formulation performed equally or better for swelling and pain reduction compared its oral equivalent and test controls. This transdermal "slow release" is a valuable and highly advantageous characteristic of the topical Delivra-ibuprofen cream and may offer significant advantages over oral medication, yielding quicker and longer lasting relief.